Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report

Abstract

Background: Conversion disorder (CD) is a relatively common psychiatric disorder likely encountered by clinical pharmacists but probably not easily identified by pharmacists. Case Summary: This is a patient case where a patient with a tremor was referred to the pharmacist led, polypharmacy, pharmacogenomics (PGx) service to rule out a PGx cause due to medication metabolism. No pharmacologic or PGx cause was found for the tremor which helped support and confirm a diagnosis of CD. Practice Implications: By working collaboratively with psychiatrists, neurologists, physical medicine colleagues, clinical pharmacists may add value to patient care by assisting with diagnoses and appropriate treatment.

Pharmacogenomic screening and differential diagnosis of conversion disorder

“…1 The following report describes the case of a patient initially thought to have a pharmacogenomic mutation that might be leading to undesirable effects of her medications, but for whom a diagnosis of conversion disorder was eventually confirmed. 2…”